Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a tumor necrosis factor (TNF) family ligand that binds on the death receptors, DR4 and DR5, activating apoptotic pathways selectively in cancer cells and thus has become a promising cancer therapeutic agent. Compound 1, isolated from Streptomyces sp. IFM 10937, has shown activity in overcoming TRAIL resistance in AGS cells. Synthesis of 1 has been accomplished from L-tyrosine in an overall high-yielding reaction sequence.
GRAPHICAL ABSTRACT
ACKNOWLEDGMENT
Research facilities provided by KFUPM are gratefully acknowledged.
SUPPORTING INFORMATION
Supplemental data for this article can be accessed on the publisher’s website.